COSCIENS Biopharma Inc. CSCIF
Set alert
6.44 USD 0.00 0.00%
At close · Oct 30
6.43 Day range 6.44
0.79 52-week range 9.50
- YTD
- +212.62%
- 1 year
- +151.56%
- Open
- 6.43
- Prev close
- 6.44
- Mkt cap
- 6.42M
- Vol
- 1.00K
- Avg vol
- 354
- EPS
- -4.12
- P/E
- 0.00
More statistics
- Low
- 6.43
- High
- 6.44
3M chart
Signals (13)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Overbought | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
Financials — quick view
CSCIF Revenue — quarterly 2.75M
CSCIF Net income — quarterly -2.70M
CSCIF EPS — quarterly -0.85
News
- COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING
- COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING
- COSCIENS ACQUIRES NUALTIS CORP.
- COSCIENS Biopharma Inc. Reports Q2 2026 Results
- COSCIENS Biopharma Inc. Completes Share Capital Amendment
- COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
- COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO
- COSCIENS Biopharma Inc. Reports Q1 2026 Results
- COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
- COSCIENS Comments on Unusual Market Activity
Your note
Sign in to keep a note on CSCIF — it syncs with the Stock Master app.